Skip to main content

Mexiletine Hydrochloride Capsules Shortage

Last Updated: April 16, 2021
Status: Resolved

Reason for the Shortage
    • Lannett did not provide a reason for the shortage.
    • Teva had mexiletine capsules on shortage due to a delay in obtaining active pharmaceutical ingredient.
Available Products
    • Mexiletine hydrochloride oral capsule, Lannett, 150 mg, bottle, 100 count, NDC 00527-4107-37
    • Mexiletine hydrochloride oral capsule, Lannett, 200 mg, bottle, 100 count, NDC 00527-4108-37
    • Mexiletine hydrochloride oral capsule, Lannett, 250 mg, bottle, 100 count, NDC 00527-4109-37
    • Mexiletine hydrochloride oral capsule, Teva, 150 mg, bottle, 100 count, NDC 00093-8739-01
    • Mexiletine hydrochloride oral capsule, Teva, 200 mg, bottle, 100 count, NDC 00093-8740-01
    • Mexiletine hydrochloride oral capsule, Teva, 250 mg, bottle, 100 count, NDC 00093-8741-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated April 16, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 10, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer